ZIPSTA
DEAD

Serial Number

85547257

Owner

ELI LILLY AND COMPANY

Attorney

ROBERT E LEE JR

Filing Date

Feb 20, 2012

Add to watchlist:

No watchlists yet
View on USPTO

ZIPSTA Trademark

Serial Number: 85547257

ZIPSTA is a trademark filed by ELI LILLY AND COMPANY on February 20, 2012. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ELI LILLY AND COMPANY (3,820 trademarks)

Entity Type: 03

Trademark Details

Filing Date

February 20, 2012

Registration Date

Not Registered

Published for Opposition

November 6, 2012

Goods & Services

Veterinary preparations for destroying vermin, namely, insecticides for use with livestock and livestock premises; antibiotics for use in livestock; veterinary preparations for the treatment of enteric clostridium infections; veterinary preparations for the prevention of enteric clostridium infections; veterinary preparations in the treatment of Cushing's disease in animals; veterinary preparations for the control and symptomatic relief of viral and bacterial infectious diseases of cattle; immunorestorative biopharmaceutical for enhancing the immune system of cattle; veterinary preparations for controlling and destroying vermin, namely, insecticides and pesticides for use with poultry and livestock animals and poultry and livestock premises; veterinary preparations, namely, vaccines, antimicrobials and other medicinal drugs for the prevention, treatment, control, or symptomatic relief of infectious, non-infectious and metabolic diseases of poultry and livestock; animal feed supplements; medicated feed and water additives for animals; veterinary preparations for food safety, namely, anti-microbial preparations for inhibiting microbiological decomposition in food and animal feed; veterinary preparations, namely, anti-microbials and vaccines for food safety and food animal processing; antibacterial pharmaceuticals; veterinary preparations for production improvement for poultry and livestock, namely, medicated feed additives for poultry and livestock and medicated water additives for poultry and livestock; diagnostic agents, tests, preparations and substances to identify pathogens or residues of biological interest for veterinary use; bactericides, namely, bacteriophage used as a human food safety agent to reduce levels of food borne pathogens carried on livestock or meat prior to being processed for human consumption; bacterial vector based vaccines relating to infection and non-infectious diseases or productivity loss in all avian, ruminant and swine species, the prevention or reduction of contamination of food produced by any or all avian, ruminant or swine species, the prevention of food-borne diseases in humans associated with contact with or consumption of food produced by any or all avian, ruminant or swine species; pathogen reduction preparations for pathogens that are in or on animals and that take the form of bacteria contaminants in meat which may be found in the livestock's digestive systems, or on the livestock during the harvest and processing phases; pathogen reduction treatment preparation for use on treating bacteria contaminants in meat which may be found in the livestock's digestive systems, or on the livestock during the harvest and processing phases; veterinary preparations containing natural plant extracts for oral administration to avian species and other livestock as an aid in managing health risks and productivity, namely, veterinary preparations for infection and non-infectious diseases or productivity loss in avian species and other livestock; Veterinary preparations for use in the treatment of fleas on pets; veterinary preparations for use in the prevention of fleas on pets; insecticides to prevent fleas on pets; transdermal drug delivery products for use on companion and food animals, namely, skin penetration medicine for pain and inflammation; veterinary preparations for companion animals in the treatment of parasitic infestations; transdermal topical solution administered by veterinarians in a surgical setting to treat pain in companion animals; veterinary preparations for companion animals in the treatment of anxiety, diabetes, hyperthyroidism, hypothyroidism, obesity, urine spraying, urinary incontinence; dental and oral disease, namely, stomatitis, Feline Odontoclastic Resorptive Lesion, periodontitis; veterinary preparations for companion animals in the treatment of chronic pain associated with osteoarthritis and cancer; veterinary preparations for companion animals in the treatment of gastrointestinal disorders associated with cholangiohepatitis, inflammatory bowel disorder, pancreatitis, gastritis, chronic colitis, enteritis; veterinary preparations for companion animals in the treatment of central nervous systems diseases and disorders, namely, cerebellar hypoplasia, cerebellar abiotrophy, laryngeal paralysis, meningoencephalitis, syringomyelia; veterinary preparations for companion animals in the treatment of neurological and neurodegenerative disorders, namely, seizure, epilepsy, neuropathies; veterinary preparations for companion animals in the treatment of parasitic infections and infestations associated with acaricides, heartworm, GI nematodes, mange, fleas; veterinary preparations for companion animals in the treatment of cardiovascular conditions namely, hypertension, cardiomyopathies, hear murmurs, heart failure; veterinary preparations for companion animals in the treatment of dermatologic conditions, namely, canine atopic dermatitis, skin rash, flea allergy, food allergy, cancer; veterinary preparations for companion animals in the treatment of chronic kidney disease and associated conditions namely, anemia, hyperphosphatemia, hypocalcemia, hypertension, cachexia; veterinary preparations for companion animals in the treatment of acute pain associated with orthopedic and soft tissue surgery, trauma, and musculoskeletal conditions; veterinary preparations for companion animals in the treatment of osteoarthritis, otitis and wound healing; veterinary preparations for companion animals in the treatment of infections, namely, upper respiratory; veterinary preparations for companion animals in the treatment of allergy atopic conditions associated with atopic dermatitis, seasonal allergies, asthma; veterinary preparations for companion animals in the treatment of liver disease, acute and chronic hepatitis; nonsurgical sterilization

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 8, 2016 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 8, 2016 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 10, 2015 EXRA
SOU EXTENSION 5 GRANTED
Jul 9, 2015 EX5G
SOU EXTENSION 5 FILED
Jun 26, 2015 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 26, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2014 EXRA
SOU EXTENSION 4 GRANTED
Dec 16, 2014 EX4G
SOU EXTENSION 4 FILED
Dec 12, 2014 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 12, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 17, 2014 EXRA
SOU EXTENSION 3 GRANTED
Jun 16, 2014 EX3G
SOU EXTENSION 3 FILED
Jun 10, 2014 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 10, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 11, 2014 EXRA
SOU EXTENSION 2 GRANTED
Feb 10, 2014 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 31, 2014 AITU
SOU EXTENSION 2 FILED
Dec 16, 2013 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 16, 2013 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 30, 2013 EXRA
SOU EXTENSION 1 GRANTED
May 28, 2013 EX1G
SOU EXTENSION 1 FILED
May 28, 2013 EXT1
SOU TEAS EXTENSION RECEIVED
May 28, 2013 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 1, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 6, 2012 NPUB
PUBLISHED FOR OPPOSITION
Nov 6, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 17, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 1, 2012 PREV
ASSIGNED TO LIE
Sep 13, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 4, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 28, 2012 GNRN
NON-FINAL ACTION E-MAILED
Mar 28, 2012 GNRT
NON-FINAL ACTION WRITTEN
Mar 28, 2012 CNRT
ASSIGNED TO EXAMINER
Mar 23, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2012 NWOS
NEW APPLICATION ENTERED
Feb 23, 2012 NWAP